Literature DB >> 3665925

Characterization of a mannosidase acting on alpha 1----3- and alpha 1----6-linked mannose residues of oligomannosidic intermediates of glycoprotein processing.

E Monis1, P Bonay, R C Hughes.   

Abstract

Baby hamster kidney (BHK) cell extracts catalyze the conversion of [3H]mannose-labelled (Man)5GlcNAc and (Man)6GlcNAc oligosaccharides to a (Man)3GlcNAc species that retains affinity for concanavalin-A-Sepharose and appears to be Man alpha 1----3[Man alpha 1----6]Man beta 1----4GlcNAc. The properties of the (Man)5GlcNAc-hydrolase activity differ from lysosomal alpha-mannosidases as well as previously described processing mannosidases acting on oligosaccharide intermediates of N-glycan assembly. Mosquito cell extracts catalyze hydrolysis of (Man)6GlcNAc but lack the (Man)5GlcNAc hydrolase activity detected in BHK cell extracts. Glycopeptide analysis has been carried out on a ricin-resistant BHK mutant RicR14 that lacks N-acetylglucosaminyl transferase I and fails to convert oligomannosidic N-glycans to complex-type chains, and mosquito cells that constitutively lack N-acetylglucosaminyl transferase I. In both cell lines, the cellular glycoproteins contain (Man)5GlcNAc oligosaccharide as the major stable component equivalent to a 15-20-fold increase compared with normal BHK cells. Although containing very high amounts of asparagine-linked (Man)5(GlcNAc)2, RicR14 cells exhibit (Man)5GlcNAc hydrolase activity at levels similar to wild-type BHK cells. This result, together with previous work [Foddy, L., Feeney, J. & Hughes, R.C. (1986) Biochem. J. 233, 697-706] showing the complete inhibition of conversion of oligomannosidic intermediates to complex-type N-glycans in BHK cells treated with swainsonine, an inhibitor of mannosidase II but not the (Man)5GlcNAc hydrolase activity, argues against a major role for the (Man)5GlcNAc hydrolase activity in N-glycan assembly and suggesting other functions for the mannosidase activity in BHK cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3665925     DOI: 10.1111/j.1432-1033.1987.tb13419.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  So what do your sugars do?

Authors:  R C Hughes
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Insect cells encode a class II alpha-mannosidase with unique properties.

Authors:  Z Kawar; K Karaveg; K W Moremen; D L Jarvis
Journal:  J Biol Chem       Date:  2001-02-09       Impact factor: 5.157

Review 3.  Protein N-glycosylation in the baculovirus-insect cell system.

Authors:  Xianzong Shi; Donald L Jarvis
Journal:  Curr Drug Targets       Date:  2007-10       Impact factor: 3.465

4.  Substrate specificity of human liver neutral alpha-mannosidase.

Authors:  S al Daher; R De Gasperi; P Daniel; S Hirani; C Warren; B Winchester
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

5.  Effects of brefeldin A on oligosaccharide processing. Evidence for decreased branching of complex-type glycans and increased formation of hybrid-type glycans.

Authors:  D Chawla; R C Hughes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

6.  Structure-activity relationship of swainsonine. Inhibition of human alpha-mannosidases by swainsonine analogues.

Authors:  I Cenci di Bello; G Fleet; S K Namgoong; K Tadano; B Winchester
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

7.  A deletion in the golgi alpha-mannosidase II gene of Caenorhabditis elegans results in unexpected non-wild-type N-glycan structures.

Authors:  Katharina Paschinger; Matthias Hackl; Martin Gutternigg; Dorothea Kretschmer-Lubich; Ute Stemmer; Verena Jantsch; Günter Lochnit; Iain B H Wilson
Journal:  J Biol Chem       Date:  2006-07-24       Impact factor: 5.157

8.  Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II.

Authors:  A Velasco; L Hendricks; K W Moremen; D R Tulsiani; O Touster; M G Farquhar
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.